Strides Pharma's Chestnut Ridge unit in New York classified as voluntary action indicated by USFDA
Published on: Feb. 5, 2026, 3:26 p.m. | Source: Daily Excelsior
NEW DELHI, Feb 5: Strides Pharma Science Ltd on Thursday said its arm Strides Pharma Inc (SPI) has received establishment inspection report from the US health regulator for its formulations unit at Chestnut Ridge in New York classifying the facility as voluntary action indicated. The facility was inspected by the United States Food and Drug Administration (USFDA) from December 17, 2025 to December 23, 2025. The inspection covered current Good Manufacturing Practices (cGMP) and included a pre-approval inspection for drug-device […]
